DK620289D0 - Analogifremgangsmaade og udgangsmateriale til fremstilling af prostaglandin e1-analoge samt cyclodextrinchlathrater og ikke-toksiske salte deraf - Google Patents

Analogifremgangsmaade og udgangsmateriale til fremstilling af prostaglandin e1-analoge samt cyclodextrinchlathrater og ikke-toksiske salte deraf

Info

Publication number
DK620289D0
DK620289D0 DK620289A DK620289A DK620289D0 DK 620289 D0 DK620289 D0 DK 620289D0 DK 620289 A DK620289 A DK 620289A DK 620289 A DK620289 A DK 620289A DK 620289 D0 DK620289 D0 DK 620289D0
Authority
DK
Denmark
Prior art keywords
analogue
cyclodextrinchlathrater
prostaglandin
preparation
toxic salts
Prior art date
Application number
DK620289A
Other languages
English (en)
Other versions
DK620289A (da
Inventor
Masaki Hayashi
Katsuichi Shimoji
Yoshinobu Arai
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of DK620289D0 publication Critical patent/DK620289D0/da
Publication of DK620289A publication Critical patent/DK620289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK620289A 1977-09-16 1989-12-08 Analogifremgangsmaade og udgangsmateriale til fremstilling af prostaglandin e1-analoge samt cyclodextrinchlathrater og ikke-toksiske salte deraf DK620289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52110504A JPS6022710B2 (ja) 1977-09-16 1977-09-16 プロスタグランジン類似化合物

Publications (2)

Publication Number Publication Date
DK620289D0 true DK620289D0 (da) 1989-12-08
DK620289A DK620289A (da) 1989-12-08

Family

ID=14537436

Family Applications (3)

Application Number Title Priority Date Filing Date
DK405078A DK405078A (da) 1977-09-16 1978-09-14 Fremgangsmaade til fremstilling af prostaglandinanaloge
DK620189A DK620189D0 (da) 1977-09-16 1989-12-08 Prostaglandin e1-analoge og cyclodextrinchlathrater og ikke-toksiske salte deraf samt middel indeholende dem
DK620289A DK620289A (da) 1977-09-16 1989-12-08 Analogifremgangsmaade og udgangsmateriale til fremstilling af prostaglandin e1-analoge samt cyclodextrinchlathrater og ikke-toksiske salte deraf

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK405078A DK405078A (da) 1977-09-16 1978-09-14 Fremgangsmaade til fremstilling af prostaglandinanaloge
DK620189A DK620189D0 (da) 1977-09-16 1989-12-08 Prostaglandin e1-analoge og cyclodextrinchlathrater og ikke-toksiske salte deraf samt middel indeholende dem

Country Status (19)

Country Link
US (2) US4215142A (da)
JP (1) JPS6022710B2 (da)
AU (1) AU527940B2 (da)
BE (1) BE870531A (da)
CA (1) CA1119169A (da)
CH (2) CH635318A5 (da)
DE (2) DE2858094C2 (da)
DK (3) DK405078A (da)
FR (2) FR2403333A1 (da)
GB (2) GB2006753B (da)
HK (1) HK82185A (da)
HU (1) HU182553B (da)
IE (1) IE47439B1 (da)
IT (2) IT1192580B (da)
LU (1) LU80235A1 (da)
MY (1) MY8600652A (da)
NL (2) NL184467C (da)
SG (1) SG58485G (da)
ZA (1) ZA785230B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2834248A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-pgf tief 2 und delta 2-pge tief 2 -reihe
DE2913856A1 (de) * 1979-04-06 1980-10-23 Hoechst Ag Neue prostaglandinderivate in der 6-keto-pge tief 1 -reihe
EP0068871B1 (en) * 1981-06-29 1986-05-07 Ono Pharmaceutical Co., Ltd. Prostaglandin analogues
JPS58164512A (ja) * 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS59163365A (ja) * 1983-03-08 1984-09-14 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物
DE3401542A1 (de) * 1984-01-18 1985-08-01 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige 6-ketoprostaglandine
JPS60181068A (ja) * 1984-02-29 1985-09-14 Teijin Ltd ６−置換プロスタグランジンｅ↓１類およびその製造法
JPS6130554A (ja) * 1984-07-23 1986-02-12 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
US4755531A (en) * 1986-08-11 1988-07-05 Syntex (U.S.A.) Inc. Thiol esters of 4,5-allenyl prostaglandins and use thereof as antigastric secretion agents
DE3704825A1 (de) * 1987-02-16 1988-08-25 Froelich Juergen Prostaglandin e1-derivate als pharmazeutische wirkstoffe und diese verbindungen enthaltende arzneimittel insbesondere zur transkutanen anwendung
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
DE3708537A1 (de) * 1987-03-13 1988-09-22 Schering Ag 6-oxoprostaglandin-e-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
JPS63202544U (da) * 1987-06-22 1988-12-27
CA2007350A1 (en) * 1989-01-10 1990-07-10 Siegfried Joachim Schon Double-walled pleated curtain
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
WO2001046134A1 (en) * 1999-12-22 2001-06-28 Alcon Universal Ltd. 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
WO2011072383A1 (en) * 2009-12-18 2011-06-23 Apotex Pharmachem Inc. Processes for the purification of lubiprostone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034003A (en) * 1974-04-11 1977-07-05 Ono Pharmaceutical Co., Ltd. 15-Cycloalkyl-prostaglandins
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
US4124601A (en) * 1976-12-30 1978-11-07 The Upjohn Company Certain 5-halo-6,9α-epoxy-14-bromo(or chloro)-PGF1 compounds
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues
US4171447A (en) * 1976-12-30 1979-10-16 The Upjohn Company Tri-halo prostaglandin intermediates

Also Published As

Publication number Publication date
FR2453851A1 (fr) 1980-11-07
GB2006753B (en) 1982-08-04
IE47439B1 (en) 1984-03-21
US4278688A (en) 1981-07-14
FR2403333B1 (da) 1982-05-07
IT7827773A0 (it) 1978-09-15
NL184467C (nl) 1989-08-01
AU527940B2 (en) 1983-03-31
US4215142A (en) 1980-07-29
DK620289A (da) 1989-12-08
IE781857L (en) 1979-03-16
IT1213051B (it) 1989-12-07
GB2006753A (en) 1979-05-10
GB2079268B (en) 1982-08-11
DK620189A (da) 1989-12-08
FR2403333A1 (fr) 1979-04-13
AU3988678A (en) 1980-03-20
HK82185A (en) 1985-11-01
DK405078A (da) 1979-03-17
HU182553B (en) 1984-02-28
ZA785230B (en) 1979-08-29
JPS6022710B2 (ja) 1985-06-03
IT8619809A0 (it) 1986-03-19
DE2840032C2 (de) 1983-12-22
DE2840032A1 (de) 1979-03-29
SG58485G (en) 1986-08-01
JPS5444639A (en) 1979-04-09
NL8203068A (nl) 1982-12-01
MY8600652A (en) 1986-12-31
NL184467B (nl) 1989-03-01
CH635318A5 (fr) 1983-03-31
CH638492A5 (fr) 1983-09-30
FR2453851B1 (fr) 1985-10-25
IT1192580B (it) 1988-04-20
DE2858094C2 (de) 1986-03-06
BE870531A (fr) 1979-03-15
NL7809368A (nl) 1979-03-20
DK620189D0 (da) 1989-12-08
GB2079268A (en) 1982-01-20
CA1119169A (en) 1982-03-02
LU80235A1 (fr) 1979-06-01

Similar Documents

Publication Publication Date Title
DK149594C (da) Analogifremgangsmaade til fremstilling af dipeptidderivater eller syreadditionssalte heraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK471479A (da) Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
DK620289D0 (da) Analogifremgangsmaade og udgangsmateriale til fremstilling af prostaglandin e1-analoge samt cyclodextrinchlathrater og ikke-toksiske salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK145260C (da) Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf
PL207835A1 (pl) Sposob etylowania monoalkilobenzenu
NO149426C (no) Analogifremgangsmaate for fremstilling av cns-aktive 3-fenylcykloalkan- eller -cykloalken-1-ol-derivater
IT1105905B (it) Composizione e procedimento per fotopolimerizzare composti insaturi
DK154704C (da) Fremgangsmaade til fremstilling af et sesquiterpenderivat eller salte deraf
DK263180A (da) Fremgangsmaade til fremstilling af substituerede 2-nitro-5-phenoxy-benzosyrer og salte deraf
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf
DK567778A (da) Fremgangsmaade til fremstilling af kvaternaere ammoniumsalte af phenylpropylaminer og phenylbutylaminer
DK148019C (da) Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf
DK147198C (da) Analogifremgangsmaade til fremstilling af 9-hydroxyethoxymethylguanin-monophosphat eller salte deraf
DK319178A (da) Fremgangsmaade til fremstilling af acylamido-2-cephem-4-carboxylsyreforbindelser og salte
DK143273C (da) Analogifremgangsmaade til fremstilling af amidinobenzyloyrimidiner og syreadditionssalte heraf
DK333279A (da) Fremgangsmaade til fremstilling af thiosubstitituerede diazacycloalkener og salte deraf
DK62878A (da) Fremgangsmaade til fremstilling af benzoheterocyclylglyoxylsyrederivater samt salte deraf
DK196878A (da) Fremgangsmaade til fremstilling af phenylglycinderivater og salte deraf
DK145375C (da) Analogifremgangsmaade til fremstilling af fenoxypropanolaminereller salte deraf
DK161149C (da) Analogifremgangsmaade til fremstilling af n-substituerede 6-oxamorphinaner og farmaceutisk acceptable salte deraf
DK144420C (da) Analogifremgangsmaade til fremstilling af vincaalkaloidderivater og salte deraf
DK150487C (da) Analogifremgangsmaade til fremstilling af triazolo-thieno-diazepin-1-oner eller alkalimetalsalte deraf
DK144599C (da) Analogifremgangsmaade til fremstilling af vincaalkaloidderivater og salte deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment